Citadel Advisors LLC has recently announced that it has increased stake in Annexon Inc. (NASDAQ:ANNX) by 24.82%. After grabbing 2.33 million shares, the institutional investor is now in possession of 0.46 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.38% having worth around $12.34 million. Moreover, The Vanguard Group, Inc. increased its share by 21100.0 to have a control over 1.55 million shares. And GMT Capital Corp. raised its holdings to 1.41 million shares by acquiring 1.41 million shares or 2.65% of the stake.
Annexon Inc. (ANNX) concluded trading on 05/25/23 at a closing price of $2.10, with 11.89 million shares of worth about $24.97 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.96% during that period and on Thursday the price saw a loss of about -59.38%. Currently the company’s common shares owned by public are about 73.86M shares, out of which, 46.49M shares are available for trading.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 8 analysts are covering the ANNX stock and their offered price forecasts bring an average price target of $15.43. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $30.00 and could fall to a lowest price of $7.00. The stock’s current price level is 86.36% above of average price target set by the analysts, while a rise to estimated low would result in gain of 70.0% for the stock. However, touching the estimated high of $30.00 would mean a gain of 93.0% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 13 times over the past 12 months. They bought 5,167,122 shares in 8 of the transactions. In 5 selling transactions, insiders dumped 10,124 shares.
Eventide Healthcare & Life Scienc, Federated Hermes Kaufmann Fund, and Pictet – Biotech are the top 3 mutual funds which are holding stakes in Annexon Inc. Eventide Healthcare & Life Scienc is currently holding 3.63 million shares of worth totaling $19.24 million. The company recently came buying 0.0 shares which brought its stake up to 6.83% of the company’s outstanding shares. Pictet – Biotech, after buying 1.26 million shares, have now control over 2.37% of the stake in the company. It holds 58032.0 shares of worth $6.67 million.
Annexon Inc. (NASDAQ: ANNX) started trading at $2.83, below -$2.34 from concluding price of the previous day. However, the stock later moved at a day high price of 2.8600, or with a loss of -59.38%. Stock saw a price change of -63.79% in past 5 days and over the past one month there was a price change of -60.75%. Year-to-date (YTD), ANNX shares are showing a performance of -59.38% which decreased to -34.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.89 but also hit the highest price of $7.65 during that period. The average intraday trading volume for Annexon Inc. shares is 473.71K. The stock is currently trading -62.11% below its 20-day simple moving average (SMA20), while that difference is down -57.03% for SMA50 and it goes to -61.94% lower than SMA200.
Citadel Advisors LLC acquired 2.33 million shares of Annexon Inc. having value of about $12.34 million. Data submitted at the U.S SEC by Citadel Advisors LLC revealed that the firm now holds 0.46 million shares in the company valued at close to $971250.0, or have control over 24.82% stake in the company. Annexon Inc. (NASDAQ: ANNX) currently have 73.86M outstanding shares and institutions hold larger chunk of about 100.70% of that. Holding of mutual funds in the company is about 28.49% while other institutional holders and individual stake holders have control over 45.29% and 27.17% of the stake respectively.
The stock has a current market capitalization of $109.60M. It has posted earnings per share of -$2.47 in the same period. It has Quick Ratio of 10.10 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ANNX, volatility over the week remained 14.71% while standing at 9.70% over the month.
Analysts are in expectations that Annexon Inc. (ANNX) stock would likely to be making an EPS of -$0.54 in the current quarter, while forecast for next quarter EPS is -$0.55 and it is -$2.16 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.56 which is -$0.5 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.96 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 23.70% while it is estimated to decrease by -1.80% in next year.
Analysts at 8 brokerage firms have issued recommendations for the Annexon Inc. (ANNX)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.60. Out of those 8 Wall Street analysts, 8 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Leave a Reply